Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Mark Goodarzi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6364-5103; OpenAlex author ID A5020656565; NIH RePORTER profile ID 8652663. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
0
Collaborators
30
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 7

  1. Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancrea… Co-author DOI 10.1016/j.pan.2026.04.001↗
  2. Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis. Co-author DOI 10.1007/s00125-025-06543-y↗
  3. Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control. Co-author DOI 10.1158/1055-9965.epi-21-0712↗
  4. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Co-author DOI 10.2337/dc19-0145↗
  5. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer. Co-author DOI 10.1016/j.jand.2017.07.005↗
  6. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rational… Last author DOI 10.1097/mpa.0000000000001168↗
  7. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Co-author DOI 10.1016/s2468-1253(16)30106-6↗

Grants 1

  1. Cedars Sinai Center for the Chronic Pancreatitis Clinical Research Consortium U01DK108314↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen Jacob Pandol · 5 shared papers, 1 shared grant, 2016–2026 · strength 1.92
  2. Dana K. Andersen · 5 shared papers, 2016–2026 · strength 0.64
  3. Phil A. Hart · 5 shared papers, 2016–2026 · strength 0.64
  4. Yogish C. Kudva · 4 shared papers, 2016–2026 · strength 0.56
  5. Melena D. Bellin · 4 shared papers, 2016–2026 · strength 0.56
  6. Dhiraj Yadav · 4 shared papers, 2016–2026 · strength 0.56
  7. Frederico G. S. Toledo · 2 shared papers, 2025–2026 · strength 0.45
  8. Kenneth Cusi · 2 shared papers, 2025–2026 · strength 0.45
  9. Walter Gwang-Up Park · 2 shared papers, 2025–2026 · strength 0.45
  10. Christopher E Forsmark · 2 shared papers, 2016–2026 · strength 0.30
  11. José Serrano · 2 shared papers, 2018–2025 · strength 0.27
  12. Maxim S. Petrov · 3 shared papers, 2018–2019 · strength 0.26
  13. Evan L Fogel · 1 shared paper, 2026 · strength 0.24
  14. William E Fisher · 1 shared paper, 2026 · strength 0.24
  15. Randall E. Brand · 1 shared paper, 2025 · strength 0.20
  16. Aida Habtezion · 3 shared papers, 2016–2018 · strength 0.19
  17. Murray Korc · 3 shared papers, 2016–2018 · strength 0.19
  18. Joseph R. Pisegna · 1 shared paper, 2022 · strength 0.16
  19. Christie Y. Jeon · 1 shared paper, 2022 · strength 0.16
  20. Harvey A. Risch · 1 shared paper, 2022 · strength 0.16
  21. Zobeida Cruz‐Monserrate · 2 shared papers, 2016–2018 · strength 0.13
  22. Jaelim Cho · 1 shared paper, 2019 · strength 0.12
  23. Aurelia Lugea · 1 shared paper, 2018 · strength 0.08
  24. William E. Fisher · 1 shared paper, 2018 · strength 0.08
  25. Guido Eibl · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.